ribociclib has been researched along with Carcinoma--Renal-Cell* in 1 studies
1 other study(ies) available for ribociclib and Carcinoma--Renal-Cell
| Article | Year |
|---|---|
Inhibition of the CDK4/6-Cyclin D-Rb Pathway by Ribociclib Augments Chemotherapy and Immunotherapy in Renal Cell Carcinoma.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cyclin D; Cyclin-Dependent Kinases; Humans; Kidney Neoplasms; Male; Mice; Mice, SCID; Protein Kinase Inhibitors; Purines; Signal Transduction; Xenograft Model Antitumor Assays | 2020 |